BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bowman CJ, Breslin WJ, Connor AV, Martin PL, Moffat GJ, Sivaraman L, Tornesi MB, Chivers S. Placental Transfer of Fc-Containing Biopharmaceuticals across Species, an Industry Survey Analysis: PLACENTAL TRANSFER OF Fc BIOPHARMACEUTICALS. Birth Defects Res B 2013;98:459-85. [DOI: 10.1002/bdrb.21089] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Schmidt A, Schmidt A, Markert UR. The road (not) taken - Placental transfer and interspecies differences. Placenta 2021;115:70-7. [PMID: 34562829 DOI: 10.1016/j.placenta.2021.09.011] [Reference Citation Analysis]
2 Prell RA, Dybdal N, Arima A, Chihaya Y, Nijem I, Halpern W. Placental and Fetal Effects of Onartuzumab, a Met/HGF Signaling Antagonist, When Administered to Pregnant Cynomolgus Monkeys. Toxicol Sci 2018;165:186-97. [PMID: 29893934 DOI: 10.1093/toxsci/kfy141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
3 Lansita JA, Mounho-zamora B. The Development of Therapeutic Monoclonal Antibodies: Overview of the Nonclinical Safety Assessment. Curr Pain Headache Rep 2015;19. [DOI: 10.1007/s11916-014-0472-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Cauvin AJ, Peters C, Brennan F. Advantages and Limitations of Commonly Used Nonhuman Primate Species in Research and Development of Biopharmaceuticals. The Nonhuman Primate in Nonclinical Drug Development and Safety Assessment. Elsevier; 2015. pp. 379-95. [DOI: 10.1016/b978-0-12-417144-2.00019-6] [Cited by in Crossref: 6] [Article Influence: 0.9] [Reference Citation Analysis]
5 Luffer-Atlas D, Reddy VR, Hilbish KG, Grace CE, Breslin WJ. PDGFRα monoclonal antibody: Assessment of embryo-fetal toxicity and time-dependent placental transfer of a murine surrogate antibody of olaratumab in mice. Birth Defects Res 2018;110:1358-71. [PMID: 30367709 DOI: 10.1002/bdr2.1403] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Neal-kluever A, Fisher J, Grylack L, Kakiuchi-kiyota S, Halpern W. Physiology of the Neonatal Gastrointestinal System Relevant to the Disposition of Orally Administered Medications. Drug Metab Dispos 2019;47:296-313. [DOI: 10.1124/dmd.118.084418] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
7 Hilbish KG, Martin JA, Stauber AJ, Edwards TL, Breslin WJ. TGF-β1 monoclonal antibody: Assessment of embryo-fetal toxicity in rats and rabbits: TGF-β1 mab embryo-fetal toxicity rat and rabbit. Birth Defects Res B 2016;107:174-84. [DOI: 10.1002/bdrb.21182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Barrow P, Villabruna L, Hoberman A, Bohrmann B, Richter WF, Schubert C. Reproductive and developmental toxicology studies with gantenerumab in PS2APP transgenic mice. Reproductive Toxicology 2017;73:362-71. [DOI: 10.1016/j.reprotox.2017.07.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
9 Moffat GJ, Retter MW, Kwon G, Loomis M, Hock MB, Hall C, Bussiere J, Lewis EM, Chellman GJ. Placental transfer of a fully human IgG2 monoclonal antibody in the cynomolgus monkey, rat, and rabbit: a comparative assessment from during organogenesis to late gestation. Birth Defects Res B Dev Reprod Toxicol 2014;101:178-88. [PMID: 24753333 DOI: 10.1002/bdrb.21105] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
10 Dingsdale H, Nan X, Garay SM, Mueller A, Sumption LA, Chacón-Fernández P, Martinez-Garay I, Ghevaert C, Barde YA, John RM. The placenta protects the fetal circulation from anxiety-driven elevations in maternal serum levels of brain-derived neurotrophic factor. Transl Psychiatry 2021;11:62. [PMID: 33462179 DOI: 10.1038/s41398-020-01176-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bowman CJ, Bouressam M, Campion SN, Cappon GD, Catlin NR, Cutler MW, Diekmann J, Rohde CM, Sellers RS, Lindemann C. Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine. Reprod Toxicol 2021;103:28-35. [PMID: 34058573 DOI: 10.1016/j.reprotox.2021.05.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Skaggs H, Chellman GJ, Collinge M, Enright B, Fuller CL, Krayer J, Sivaraman L, Weinbauer GF. Comparison of immune system development in nonclinical species and humans: Closing information gaps for immunotoxicity testing and human translatability. Reprod Toxicol 2019;89:178-88. [PMID: 31233776 DOI: 10.1016/j.reprotox.2019.06.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
13 Hey A, Hill M, Calonder C, DeLise AM, Grossi AB, Pique C, Marsden E. "Simulect" as a model compound for assessing placental transfer of monoclonal antibodies in minipigs. Reprod Toxicol 2020;91:142-6. [PMID: 31698003 DOI: 10.1016/j.reprotox.2019.10.007] [Reference Citation Analysis]
14 Breslin WJ, Hilbish KG, Cannady EA, Edwards TL. Fertility and Embryo-Fetal Development Assessment in Rats and Rabbits with Evacetrapib: A Cholesteryl Ester Transfer Protein Inhibitor. Birth Defects Res 2017;109:513-27. [PMID: 28398618 DOI: 10.1002/bdr2.1022] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Catlin NR, Mitchell AZ, Potchoiba MJ, O'Hara DM, Wang M, Zhang M, Weinbauer GF, Bowman CJ. Placental transfer of 125 iodinated humanized immunoglobulin G2Δa in the cynomolgus monkey. Birth Defects Res 2020;112:105-17. [PMID: 31746560 DOI: 10.1002/bdr2.1615] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Crawford D, Friedman M. Evaluation of the Developmental Toxicity of Vedolizumab, an α4β7 Receptor Antagonist, in Rabbit and Nonhuman Primate. Int J Toxicol 2019;38:395-404. [PMID: 31364424 DOI: 10.1177/1091581819864105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Katagiri R, Ishihara-hattori K, Frings W, Amano J, Fuchs A, Chiba S. Effects of SA237, a humanized anti-interleukin-6 receptor monoclonal antibody, on pre- and postnatal development in cynomolgus monkey: Effects of SA237, IL-6R Blockade, in Cynomolgus Monkey. Birth Defects Research 2017;109:843-56. [DOI: 10.1002/bdr2.1036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Moriyama T, Kakiuchi D, Grasso L, Hutto DL, Fernando D, Schweizer C. Farletuzumab, a monoclonal antibody directed against folate receptor alpha, shows no evidence of teratogenicity in cynomolgus monkeys. Reprod Toxicol 2018;79:89-95. [PMID: 29928988 DOI: 10.1016/j.reprotox.2018.06.007] [Reference Citation Analysis]
19 Breslin WJ, Hilbish KG, Martin JA, Halstead CA, Edwards TL. Developmental Toxicity and Fertility Assessment in Rabbits with Tabalumab: A Human IgG4 Monoclonal Antibody: TABALUMAB REPRODUCTIVE ASSESSMENT RABBIT. Birth Defects Res B 2015;104:117-28. [DOI: 10.1002/bdrb.21147] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
20 Brennan FR, Cauvin A, Tibbitts J, Wolfreys A. Optimized nonclinical safety assessment strategies supporting clinical development of therapeutic monoclonal antibodies targeting inflammatory diseases. Drug Dev Res 2014;75:115-61. [PMID: 24782266 DOI: 10.1002/ddr.21173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
21 Jacobsen B, Hill M, Reynaud L, Hey A, Barrow P. FcRn Expression on Placenta and Fetal Jejunum during Early, Mid-, and Late Gestation in Minipigs. Toxicol Pathol 2016;44:486-91. [PMID: 26516163 DOI: 10.1177/0192623315610821] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
22 Bowman CJ, Chapin RE. Goldilocks’ Determination of What New In Vivo Data are “Just Right” for Different Common Drug Development Scenarios, Part 1: Goldilocks’ determination of what new in vivo data. Birth Defects Res B 2016;107:185-94. [DOI: 10.1002/bdrb.21184] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
23 Breslin WJ, Hilbish KG, Page TJ, Coutant DE. Assessment of fetal exposure risk following seminal excretion of a therapeutic IgG4 (T-IgG4) monoclonal antibody using a rabbit model. Reprod Toxicol 2014;48:124-31. [PMID: 24863471 DOI: 10.1016/j.reprotox.2014.05.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
24 Rocca M, Morford LL, Blanset DL, Halpern WG, Cavagnaro J, Bowman CJ. Applying a weight of evidence approach to the evaluation of developmental toxicity of biopharmaceuticals. Regul Toxicol Pharmacol 2018;98:69-79. [PMID: 30009863 DOI: 10.1016/j.yrtph.2018.07.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
25 Gould J, Callis CM, Dolan DG, Stanard B, Weideman PA. Special endpoint and product specific considerations in pharmaceutical acceptable daily exposure derivation. Regul Toxicol Pharmacol 2016;79 Suppl 1:S79-93. [PMID: 27233924 DOI: 10.1016/j.yrtph.2016.05.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
26 Catlin NR, Cappon GD, Engel S, Rohde C, Nowland WS, Buitrago S, Scully I, Anderson AS, Bowman CJ. Maternal immunization with Group B Streptococcus six-valent polysaccharide conjugate vaccine supported by lack of toxicity in rat and rabbit fertility and developmental toxicity studies. Birth Defects Res 2021;113:1343-56. [PMID: 34516044 DOI: 10.1002/bdr2.1953] [Reference Citation Analysis]
27 Breslin WJ, Hilbish KG, Martin JA, Halstead CA, Newcomb DL, Chellman GJ. An Enhanced Pre- and Postnatal Development Study in Cynomolgus Monkeys with Tabalumab: A Human IgG4 Monoclonal Antibody. Birth Defects Res B Dev Reprod Toxicol 2015;104:100-16. [PMID: 26195230 DOI: 10.1002/bdrb.21146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
28 Szikora B, Hiripi L, Bender B, Kacskovics I, Iliás A. Characterization of the interactions of rabbit neonatal Fc receptor (FcRn) with rabbit and human IgG isotypes. PLoS One 2017;12:e0185662. [PMID: 28957416 DOI: 10.1371/journal.pone.0185662] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]